Pluristyx's platform technology was developed specifically to overcome this challenge. This Breakthrough T1D collaboration will fund the use of precise gene editing to engineer Pluristyx's exclusively ...

Nita Limdi, Pharm.D., Ph.D. More than 10,000 Alabamians have received genetic testing that could change the course of their health through the Alabama Genomic Health Initiative. Supported by the State ...

AAV-SLB101 is a rationally designed capsid developed for enhanced skeletal muscle, cardiac tropism, and reduced biodistribution to the liver.

A Kingston research team has created a patented 3D-printed surgical biopsy tool that allows scientists to map and study ...

Researchers have mapped the regulatory elements that control the FOXP3 gene, which is implicated in maintaining balance in ...

Each year, a single cow can belch about 200 pounds of methane. The powerful greenhouse gas is 27 times more potent at ...

With the global technical textiles market heading toward $200B by 2030 , KBLB’s timing could enable early adoption and prototype work for 2026 procurement cycles, especially in high-performance and ...

Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a ...

The food biotechnology market is projected to grow substantially over the next decade, rising from an estimated USD 32.5 ...

Growing concerns over foodborne illness and shifting consumer expectations for safe, transparent, and minimally processed food are accelerating the adoption of advanced pathogen detection technologies ...

New simulations reveal interstellar objects don't arrive uniformly, with concentrations from the solar apex and galactic ...